COVID Transmission: A Scientist’s Insight on What Matters
/0 Comments/in COVID Health, COVID Podcasts, Featured, Healthcare, Podcast Hubwonk, rCOVID /by Editorial StaffJoin Joe Selvaggi and Pioneer Institute co-host Bill Smith as they talk with Harvard Medical School’s Dr. Ed Nardell about his scientific observations on how the novel coronavirus is spread and what can be done to make our schools, buildings, and lives in public safer.
Guest:
Dr. Ed Nardell is a professor in the Departments of Medicine and of Global Health and Social Medicine at Harvard Medical School and an associate professor in the Departments of Immunology and Infectious Diseases and of Environmental Health at the Harvard School of Public Health. His research interests involve the control of tuberculosis under resource-limited conditions, with a focus on the pathogenesis of drug-resistant tuberculosis, its airborne transmission, and transmission control in institutions. Another long-standing research avenue is the application of germicidal irradiation to reduce airborne transmission.
Get Our COVID-19 News, Tips & Resources!
Recent Episodes
Inflationary Debt Spiral: Fiscal Cliff Getting Closer, Faster
Identity Politics Ideology: Woke’s Orthodoxy and Opposition to Liberal Values
Federal Firearm Forfeiture: SCOTUS Considers Gun Rights and Due Process
Diversity’s Dubious Definition: Harvard Case Spells End to Racial Classifications
Untangling Unsheltered Encampments: Home Is Where the Help Lies
Ruining Research Rewards: Price Controls Come for University Patents and Products
Farmers Welfare Bill: Rethinking Costly and Environmentally Distortive Subsidies
Predatory Tax Ruling: Supreme Court Closes Door on Home Equity Theft
Sweden’s Pandemic Paradigm: Does Trust in Citizenry Save Lives
Breast Cancer Risk: Testing to Tailored Screening, Treatment, and Prevention
Landlord’s Foreseeable Duty: Who Is Liable When Crime Lands on the Doorstep?
Trump’s Trial’s Tribulations: Legal Merits of Four Federal Felony Fraud Indictments
Black Box Budget: Late, Loaded, and Lacking Transparency
Sabotaging Strategic Success: How Price Controls Could Imperil U.S. Pharma Industry